Using digital tools to help patients with atrial fibrillation reduce alcohol consumption
Digital Interventions to Study and Influence the Alcohol-Atrial Fibrillation Connection
This study is creating a friendly smartphone app to help people with atrial fibrillation cut down on alcohol, offering personalized tips and support to encourage healthier choices.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10980256 on NIH RePORTER |
What this research studies
This research aims to develop a smartphone application designed to help patients with atrial fibrillation (AF) reduce their alcohol intake. By collaborating with AF patients and experts in behavioral change, the project will create a user-friendly app that provides personalized feedback on the relationship between alcohol consumption and AF episodes. The app will also offer real-time encouragement for abstinence and utilize data from smartwatches to enhance its effectiveness. The goal is to leverage technology to promote healthier behaviors in patients at risk of AF.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with atrial fibrillation who also consume alcohol.
Not a fit: Patients who do not have atrial fibrillation or those who do not consume alcohol may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of atrial fibrillation episodes in patients who consume alcohol.
How similar studies have performed: Previous research has shown that digital interventions can effectively promote behavior change, particularly in reducing alcohol consumption among patients with similar health conditions.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Marcus, Gregory M — University of California, San Francisco
- Study coordinator: Marcus, Gregory M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.